[ad_1]
China’s first COVID-19 vaccine test shows success, protects Indian monkeys from coronavirus and nbsp | & nbspPhoto Credit: & nbspGetty Images
New Delhi: In another significant development in the race to find a cure for the deadly novel coronavirus, Chinese scientists said they successfully tested the country’s first vaccine against COVID-19 in monkeys. PiCoVacc, an inactivated COVID-19 vaccine by Sinovac Biotech, based in Beijing, has reportedly shown promising results as the experimental vaccine could help protect rhesus macaques, a type of monkey originating in India. , of the virus.
For the trial, the researchers injected the vaccine into the monkeys who were then exposed to SARS-CoV-2 which causes COVID-19 three weeks later. The report in Science magazine He stated that the vaccine triggered an immune response to produce antibodies against the virus. These antibodies can also attack normal viruses.
The researchers observed that the monkeys who administered the largest dose of PiCoVacc did not have the virus in their lungs after a week, while the monkeys who did not receive the vaccine contracted the virus and developed severe pneumonia.
Reports suggest that China has been testing the vaccine in humans since mid-April. Furthermore, another vaccine made by a Chinese military institution is currently being tested in humans. Meanwhile, both Italy and Israel this week claimed to be successful in developing COVID-19 vaccines.
For full coverage on the coronavirus pandemic, click here. Join the Times Group initiative #MaskIndia. Share an image with your homemade mask on your social handles using #MaskIndia. The best image will appear in TOI and maskindia.com
